Results 241 to 250 of about 6,688,553 (311)

Cell surface CD11c as a neutrophil aging marker molecule

FEBS Open Bio, EarlyView.
Cell surface CD11chi neutrophils were more aged and had better phagocytic function than CD11c−/lo neutrophils. Transcriptomic analysis of CD11chi neutrophils and CD11c−/lo neutrophils in pediatric population showed that the most difference was seen in infants.
Sophia Koutsogiannaki, Fahd Alhamdan, Erik Malm, Marie Bermudez, Samuel Y. Kim, Koichi Yuki   +5 more
wiley   +1 more source

Subtotal cholecystectomy as a bailout strategy in difficult cholecystectomy: Outcomes and patient selection criteria. [PDF]

Ann Hepatobiliary Pancreat Surg
Öcal İH, Hatipoğlu S.
europepmc   +1 more source

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

FEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

Prognostic Models for Patient Selection in Palliative Bone Radiotherapy: A Systematic Review. [PDF]

Cureus
Martins FA, Brito N, Sousa D.
europepmc   +1 more source

Type I interferons modulate autophagy to shape gemcitabine response in pancreatic cancer cells

FEBS Open Bio, EarlyView.
Type I interferons differentially modulate autophagy and the response of pancreatic cancer cells to gemcitabine. IFNα2b stimulates autophagic flux and protects cells from gemcitabine‐induced cell death, contributing to chemoresistance. In contrast, IFNβ1a inhibits autophagosome formation and enhances gemcitabine‐induced cell death, resulting in ...
Lucy E. Bonilla, Martín M. Ledesma, Santiago A. Behr, Matías A. Pibuel, María L. Palanek, Daniel H. Grasso, Maria N. Garcia, Juan Garona, Silvina L. Lompardía, Elida Álvarez, Daniela L. Papademetrio   +10 more
wiley   +1 more source

Optimizing the "right" patient selection for treatment for sickle cell disease. [PDF]

Hematology Am Soc Hematol Educ Program
Colombatti R, Reggiani G.
europepmc   +1 more source

Correction to: "Diazoxide Choline Extended-Release (DCCR) Use in Prader-Willi Syndrome: Patient Selection, Dosing, and Management". [PDF]

J Endocr Soc
europepmc   +1 more source

Lumbar Sympathetic Radiofrequency Ablation for Peripheral Arterial Disease: Considerations Regarding Patient Selection and Interpretation of Short-Term Outcomes [Letter]. [PDF]

J Pain Res
Çelik G.
europepmc   +1 more source

Artificial intelligence for patient selection in pulsed-field ablation: promise, pragmatism, and the need for standards. [PDF]

Europace
Rohrer U, Duncker D.
europepmc   +1 more source

Vestibular schwannoma microsurgery in the era of multimodal treatment: advances in technique and patient selection. [PDF]

J Neurooncol
Albalkhi I, Musmar B, Adeeb N, Abou-Al-Shaar H, Morcos JJ.   +4 more
europepmc   +1 more source